These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19534679)

  • 1. Antibacterial activity of lipophilic fluoroquinolone derivatives.
    de Almeida CG; Diniz CG; Silva VL; Saraiva MF; Le Hyaric M; de Almeida MV
    Med Chem; 2009 Sep; 5(5):419-21. PubMed ID: 19534679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitubercular activity of lipophilic moxifloxacin and gatifloxacin derivatives.
    de Almeida MV; Saraiva MF; de Souza MV; da Costa CF; Vicente FR; Lourenço MC
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5661-4. PubMed ID: 17804222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro antibacterial activity of gemifloxacin derivatives containing a substituted benzyloxime moiety.
    Feng L; Lv K; Liu M; Wang S; Zhao J; You X; Li S; Cao J; Guo H
    Eur J Med Chem; 2012 Sep; 55():125-36. PubMed ID: 22841282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis.
    Anand RS; Somasundaram S; Doble M; Paramasivan CN
    BMC Struct Biol; 2011 Dec; 11():47. PubMed ID: 22152119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens.
    Callegan MC; Ramirez R; Kane ST; Cochran DC; Jensen H
    Adv Ther; 2003; 20(5):246-52. PubMed ID: 14964344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzalkonium chloride enhances antibacterial activity of gatifloxacin and reduces its propensity to select for fluoroquinolone-resistant strains.
    Hesje CK; Borsos SD; Blondeau JM
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):329-34. PubMed ID: 19650708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-4-amino-4-methylpiperidin-1-yl) fluoroquinolone derivatives.
    Wang JX; Zhang YB; Liu ML; Wang B; Chai Y; Li SJ; Guo HY
    Eur J Med Chem; 2011 Jun; 46(6):2421-6. PubMed ID: 21481984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone derivatives.
    Chai Y; Wan ZL; Wang B; Guo HY; Liu ML
    Eur J Med Chem; 2009 Oct; 44(10):4063-9. PubMed ID: 19481308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro antibacterial activity of a series of novel gatifloxacin derivatives.
    Chai Y; Liu ML; Lv K; Feng LS; Li SJ; Sun LY; Wang S; Guo HY
    Eur J Med Chem; 2011 Sep; 46(9):4267-73. PubMed ID: 21764484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones.
    Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL
    Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterials.
    McPherson JC; Runner R; Buxton TB; Hartmann JF; Farcasiu D; Bereczki I; Roth E; Tollas S; Ostorházi E; Rozgonyi F; Herczegh P
    Eur J Med Chem; 2012 Jan; 47(1):615-8. PubMed ID: 22093760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD; D'Azevedo PA; Francisco W
    Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antibacterial activity of nitroaryl thiadiazole-gatifloxacin hybrids.
    Jazayeri S; Moshafi MH; Firoozpour L; Emami S; Rajabalian S; Haddad M; Pahlavanzadeh F; Esnaashari M; Shafiee A; Foroumadi A
    Eur J Med Chem; 2009 Mar; 44(3):1205-9. PubMed ID: 18950903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.
    Kowalski RP; Dhaliwal DK; Karenchak LM; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2003 Sep; 136(3):500-5. PubMed ID: 12967804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in-vitro antimycobacterial activity of fluoroquinolone derivatives containing a coumarin moiety.
    Guo Q; Liu ML; Feng LS; Lv K; Guan Y; Guo HY; Xiao CL
    Arch Pharm (Weinheim); 2011 Dec; 344(12):802-9. PubMed ID: 21989627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial properties of new 8-nitrofluoroquinolone derivatives.
    Al-Hiari YM; Al-Mazari IS; Shakya AK; Darwish RM; Abu-Dahab R
    Molecules; 2007 Jun; 12(6):1240-58. PubMed ID: 17876293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in-vitro antibacterial activity of 7-(3-aminopyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivatives.
    Guo X; Bai XG; Li YL; An ZJ; Xu LX; Han LY; Liu ML; Guo HY; Wang YC
    Arch Pharm (Weinheim); 2011 Aug; 344(8):523-9. PubMed ID: 21656543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, antimycobacterial and antibacterial evaluation of l-[(1R, 2S)-2-fluorocyclopropyl]fluoroquinolone derivatives containing an oxime functional moiety.
    Liu H; Huang J; Wang J; Wang M; Liu M; Wang B; Guo H; Lu Y
    Eur J Med Chem; 2014 Oct; 86():628-38. PubMed ID: 25218911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro antibacterial activity of novel fluoroquinolone derivatives containing substituted piperidines.
    Chai Y; Liu M; Wang B; You X; Feng L; Zhang Y; Cao J; Guo H
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5195-8. PubMed ID: 20667731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms.
    Blondeau JM; Laskowski R; Bjarnason J; Stewart C
    Int J Antimicrob Agents; 2000 Feb; 14(1):45-50. PubMed ID: 10717500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.